Phase I/II trial of autophagy inhibition in combination with neoadjuvant gemcitabine in patients with high-risk pancreatic adenocarcinoma: Safety, clinical response, and correlative studies

被引：3
|
作者：
Lotze, Michael T.
Boone, Brian A.
Zureikat, Amer H.
Bahary, Nathan
Lehman, David
Liotta, Lance A.
Zeh, Herbert J.
机构：
[1] Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] George Mason Univ, Manassas, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
218
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II Trial of Autophagy Inhibition in Combination with Neoadjuvant Gemcitabine in High-risk Pancreatic Adenocarcinoma: Safety, Clinical Response, and Correlative Studies
    Boone, B. A.
    Lotze, M. T.
    Zureikat, A. H.
    Bahary, N.
    Singhi, A. D.
    Bartlett, D. L.
    Espina, V.
    Liotta, L. A.
    Zeh, H. J.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S7 - S7
  • [2] Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
    Brian A. Boone
    Nathan Bahary
    Amer H Zureikat
    A. James Moser
    Daniel P Normolle
    Wen-Chi Wu
    Aatur D. Singhi
    Phillip Bao
    David L Bartlett
    Lance A Liotta
    Virginia Espina
    Patricia Loughran
    Michael T. Lotze
    Herbert J. Zeh
    Annals of Surgical Oncology, 2015, 22 : 4402 - 4410
  • [3] Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
    Boone, Brian A.
    Bahary, Nathan
    Zureikat, Amer H.
    Moser, A. James
    Normolle, Daniel P.
    Wu, Wen-Chi
    Singhi, Aatur D.
    Bao, Phillip
    Bartlett, David L.
    Liotta, Lance A.
    Espina, Virginia
    Loughran, Patricia
    Lotze, Michael T.
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (13) : 4402 - 4410
  • [4] Phase II trial of high-dose gemcitabine in patients with metastatic pancreatic adenocarcinoma
    Scheithauer, W
    Kornek, G
    Ulrich-Pur, H
    Raderer, M
    Fiebiger, W
    Zickero, G
    Pidlich, J
    Greul, R
    Schneeweiss, B
    Depisch, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S147 - S147
  • [5] A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
    Ulrich-Pur, H
    Kornek, GV
    Raderer, M
    Haider, K
    Kwasny, W
    Depisch, D
    Greul, R
    Schneeweiss, B
    Krauss, G
    Funovics, J
    Scheithauer, W
    CANCER, 2000, 88 (11) : 2505 - 2511
  • [6] Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma:: a randomized phase II trial
    Scheithauer, W
    Schüll, B
    Ulrich-Pur, H
    Schmid, K
    Raderer, M
    Haider, K
    Kwasny, W
    Depisch, D
    Schneeweiss, B
    Lang, F
    Kornek, GV
    ANNALS OF ONCOLOGY, 2003, 14 (01) : 97 - 104
  • [7] Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I resultsA phase I clinical trial
    Dana B. Cardin
    Laura W. Goff
    Emily Chan
    Jennifer G. Whisenant
    G. Dan Ayers
    Naoko Takebe
    Lori R. Arlinghaus
    Thomas E. Yankeelov
    Jordan Berlin
    Nipun Merchant
    Investigational New Drugs, 2018, 36 : 442 - 450
  • [8] Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma
    AlMasri, Samer S.
    Zenati, Mazen S.
    Desilva, Annissa
    Nassour, Ibrahim
    Boone, Brian A.
    Singhi, Aatur D.
    Bartlett, David L.
    Liotta, Lance A.
    Espina, Virginia
    Loughran, Patricia
    Lotze, Michael T.
    Paniccia, Alessandro
    Zeh, Herbert J.
    Zureikat, Amer H.
    Bahary, Nathan
    CANCER MEDICINE, 2021, 10 (20): : 7233 - 7241
  • [9] The impact of neoadjuvant weekly ixabepilone for high-risk prostate cancer: A phase I/II clinical trial.
    Layton, Jodi Lyn
    Plette, Angela Marie
    Renzulli, Joseph F.
    Miller, E. Bradley
    Safran, Howard
    Mega, Anthony E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [10] A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
    Cook, Natalie
    Basu, Bristi
    Smith, Donna-Michelle
    Gopinathan, Aarthi
    Evans, Jeffry
    Steward, William P.
    Palmer, Daniel
    Propper, David
    Venugopal, Balaji
    Hategan, Mirela
    Anthoney, D. Alan
    Hampson, Lisa V.
    Nebozhyn, Michael
    Tuveson, David
    Farmer-Hall, Hayley
    Turner, Helen
    McLeod, Robert
    Halford, Sarah
    Jodrell, Duncan
    BRITISH JOURNAL OF CANCER, 2018, 118 (06) : 793 - 801
12345